Manipulating systemic and mucosal immune responses with skin-deliverable adjuvants

Keyphrases

• Mucosal Surfaces 100%
• Mucosal Immune Response 100%
• Systemic Immune Response 100%
• Lymphocyte Subsets 66%
• Ovalbumin 66%
• Mucosal Adjuvant 66%
• Vaccine Delivery 66%
• Thymus 33%
• Liver 33%
• Bacterial Pathogens 33%
• Lung 33%
• Mode of Action 33%
• Spleen 33%
• Flow Cytometric Analysis 33%
• Vaccination 33%
• Intranasal 33%
• Plethora 33%
• Lymphoid Tissue 33%
• Sheep 33%
• Mucosal Epithelium 33%
• Mucosal Immunity 33%
• Cytotoxic T Cell Response 33%
• Immunization Strategy 33%
• Viral Pathogens 33%
• Cholera Toxin B 33%
• Novel Adjuvant 33%
• Adjuvanted 33%
• IgG Antibody 33%
• Delivery Vehicle 33%
• Adjuvant System 33%
• IgA Antibody 33%
• IgA Responses 33%
• Granulomatous Lesion 33%
• Vaccinologist 33%
• Mucosal IgG 33%
• Mucosal Delivery 33%
• Mucosal IgA 33%
• Cost-effective Strategy 33%
• Intradermal Delivery 33%
• Leukocyte Trafficking 33%
• Remobilization 33%
• Peyer's Patches 33%
• Protective Immune Response 33%

Immunology and Microbiology

• Adjuvant 100%
• Lymphocyte Subpopulation 100%
• Mucosal Immune Response 100%
• Immunology 100%
• Thymus 50%
• Immune Response 50%
• Infectious Agent 50%
• Mucosal Immunity 50%
• Immunoglobulin A 50%
• Lymphoid Tissue 50%
• Cytotoxic T Cell 50%
• Microsphere 50%
• Immunoglobulin A Antibody 50%
• Cholera Toxin 50%
• Peyer's Patch 50%
• Granuloma 50%
• Lymphocyte 50%

Medicine and Dentistry

• Adjuvant 100%
• Mucosal Surface 100%
• Mucosal Immune Response 100%
• Lymphocyte Subpopulation 66%
• Ovalbumin 66%
• Disease 33%
• Immune Response 33%
• Pathogen 33%
• Health Care Cost 33%
• Lymphatic Tissue 33%
• Immunoglobulin A 33%
• Cytotoxic T-Cell 33%
• Cholera Toxin 33%
• Peyer's Patch 33%
• Thymus 33%
• T-Cell Response 33%
• Mucosal Immunity 33%
• Granulomatosis 33%
• Immunoglobulin A Antibody 33%
• Microsphere 33%
• Lung 33%
• Lymphocyte 33%